| 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus M Aringer, K Costenbader, D Daikh, R Brinks, M Mosca, ... Arthritis & rheumatology 71 (9), 1400-1412, 2019 | 2681 | 2019 |
| Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor M Miyara, Y Yoshioka, A Kitoh, T Shima, K Wing, A Niwa, C Parizot, ... Immunity 30 (6), 899-911, 2009 | 2517 | 2009 |
| Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 S Rust, M Rosier, H Funke, J Real, Z Amoura, JC Piette, JF Deleuze, ... Nature genetics 22 (4), 352-355, 1999 | 1800 | 1999 |
| Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of … GK Bertsias, M Tektonidou, Z Amoura, M Aringer, I Bajema, JHM Berden, ... Annals of the rheumatic diseases 71 (11), 1771-1782, 2012 | 1231 | 2012 |
| The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation CG Skorpen, M Hoeltzenbein, A Tincani, R Fischer-Betz, E Elefant, ... Annals of the rheumatic diseases 75 (5), 795-810, 2016 | 1074 | 2016 |
| IgA dominates the early neutralizing antibody response to SARS-CoV-2 D Sterlin, A Mathian, M Miyara, A Mohr, F Anna, L Claër, P Quentric, ... Science translational medicine 13 (577), eabd2223, 2021 | 964 | 2021 |
| The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria International Team for the Revision of the International Criteria for Behçet ... Journal of the european Academy of Dermatology and Venereology 28 (3), 338-347, 2014 | 953 | 2014 |
| EULAR recommendations for the management of antiphospholipid syndrome in adults MG Tektonidou, L Andreoli, M Limper, Z Amoura, R Cervera, ... Annals of the rheumatic diseases 78 (10), 1296-1304, 2019 | 921 | 2019 |
| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 885 | 2021 |
| EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and … L Andreoli, GK Bertsias, N Agmon-Levin, S Brown, R Cervera, ... Annals of the rheumatic diseases 76 (3), 476-485, 2017 | 831 | 2017 |
| Treat-to-target in systemic lupus erythematosus: recommendations from an international task force RF Van Vollenhoven, M Mosca, G Bertsias, D Isenberg, A Kuhn, ... Annals of the rheumatic diseases 73 (6), 958-967, 2014 | 798 | 2014 |
| Erdheim-Chester disease clinical and radiologic characteristics of 59 cases C Veyssier-Belot, P Cacoub, D Caparros-Lefebvre, J Wechsler, B Brun, ... Medicine 75 (3), 157-169, 1996 | 770 | 1996 |
| Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients R Cervera, R Serrano, GJ Pons-Estel, L Ceberio-Hualde, Y Shoenfeld, ... Annals of the rheumatic diseases 74 (6), 1011-1018, 2015 | 766 | 2015 |
| Two-year, randomized, controlled trial of belimumab in lupus nephritis R Furie, BH Rovin, F Houssiau, A Malvar, YKO Teng, G Contreras, ... New England Journal of Medicine 383 (12), 1117-1128, 2020 | 687 | 2020 |
| High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses J Haroche, F Charlotte, L Arnaud, A Von Deimling, Z Hélias-Rodzewicz, ... Blood, The Journal of the American Society of Hematology 120 (13), 2700-2703, 2012 | 678 | 2012 |
| Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort M Pouletty, C Borocco, N Ouldali, M Caseris, R Basmaci, N Lachaume, ... Annals of the rheumatic diseases 79 (8), 999-1006, 2020 | 625 | 2020 |
| Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E … J Haroche, F Cohen-Aubart, JF Emile, L Arnaud, P Maksud, F Charlotte, ... Blood, The Journal of the American Society of Hematology 121 (9), 1495-1500, 2013 | 623 | 2013 |
| Global natural regulatory T cell depletion in active systemic lupus erythematosus M Miyara, Z Amoura, C Parizot, C Badoual, K Dorgham, S Trad, D Nochy, ... The Journal of Immunology 175 (12), 8392-8400, 2005 | 609 | 2005 |
| The immune paradox of sarcoidosis and regulatory T cells M Miyara, Z Amoura, C Parizot, C Badoual, K Dorgham, S Trad, ... The Journal of experimental medicine 203 (2), 359-370, 2006 | 503 | 2006 |
| Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data M Mahévas, VT Tran, M Roumier, A Chabrol, R Paule, C Guillaud, E Fois, ... Bmj 369, 2020 | 491 | 2020 |
